- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-5996
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Advances in GLP-1 treatment: focus on oral semaglutide ; volume:13 ; number:1 ; day:15 ; month:9 ; year:2021 ; pages:1-13 ; date:12.2021
Diabetology & metabolic syndrome ; 13, Heft 1 (15.9.2021), 1-13, 12.2021
- Creator
-
Eliaschewitz, Freddy G.
Canani, Luis Henrique
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13098-021-00713-9
- URN
-
urn:nbn:de:101:1-2021112619072530262000
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eliaschewitz, Freddy G.
- Canani, Luis Henrique
- SpringerLink (Online service)
Other Objects (12)
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Oral Semaglutide: Dosage in Special Situations
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Semaglutide
Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
A Review on the Efficacy and Safety of Oral Semaglutide
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Oral Semaglutide: Dosage in Special Situations
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Semaglutide
Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
A Review on the Efficacy and Safety of Oral Semaglutide
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Oral Semaglutide: Dosage in Special Situations
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
Semaglutide
Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
A Review on the Efficacy and Safety of Oral Semaglutide
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1–2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis
Oral semaglutide in kidney transplant recipients with metabolic syndrome: three Japanese cases